Urea Cycle News and Research

RSS
Urea cycle disorders are congenital diseases that are caused by a dysfunctional urea cycle. The genetics and biochemistry of these disorders have been extensively studied. They are the result of a deficiency of one of the six enzymes that catalyze the various biochemical reactions in the urea cycle which converts ammonia to urea for removal via urine.
Regenerative medicine scientist receives $1.3 million to study stem cell therapy for liver failure

Regenerative medicine scientist receives $1.3 million to study stem cell therapy for liver failure

New genome editing tool used to heal genetic disease

New genome editing tool used to heal genetic disease

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Depleted metabolic enzymes contribute to tumor growth in renal cancer

Depleted metabolic enzymes contribute to tumor growth in renal cancer

Genevac’s HCl-resistant EZ-2 evaporator offers reliable sample preparation for neonatal screening

Genevac’s HCl-resistant EZ-2 evaporator offers reliable sample preparation for neonatal screening

NCI selects UTSW cancer researcher to receive Outstanding Investigator Award

NCI selects UTSW cancer researcher to receive Outstanding Investigator Award

Research suggests novel approach to treating deadly pancreatic cancer

Research suggests novel approach to treating deadly pancreatic cancer

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Discovery of early biomarkers paves way for new insight into Huntington's disease

Discovery of early biomarkers paves way for new insight into Huntington's disease

New gene cut-and-paste methods help correct disease-causing mutation in animal model

New gene cut-and-paste methods help correct disease-causing mutation in animal model

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Arcturus to exhibit new mRNA therapeutics pipeline at two healthcare conferences

Arcturus to exhibit new mRNA therapeutics pipeline at two healthcare conferences

Promethera Biosciences completes €25.33 million ($31.4 million) Series C fundraising

Promethera Biosciences completes €25.33 million ($31.4 million) Series C fundraising

Newly developed agent filters out toxins from body in the event of overdose

Newly developed agent filters out toxins from body in the event of overdose

Phase 2 trial results show GPB reduces hepatic encephalopathy episodes in patients with cirrhosis

Phase 2 trial results show GPB reduces hepatic encephalopathy episodes in patients with cirrhosis

Tackling orphan diseases: an interview with Damian Marron, CEO, TxCell

Tackling orphan diseases: an interview with Damian Marron, CEO, TxCell

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Promethera Biosciences completes patient enrolment for first clinical trial of HepaStem

Promethera Biosciences completes patient enrolment for first clinical trial of HepaStem

Polyamine-deficient diets effective as pain relief treatment for chronic and acute pain

Polyamine-deficient diets effective as pain relief treatment for chronic and acute pain

Argininosuccinic aciduria (ASA) and gene therapy: an interview with Dr Julien Baruteau, UCL Institute for Women's Health, London

Argininosuccinic aciduria (ASA) and gene therapy: an interview with Dr Julien Baruteau, UCL Institute for Women's Health, London